Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
It’s not all about muscle: fibroadipogenic progenitors contribute to facioscapulohumeral muscular dystrophy
Carlo Serra, Kathryn R. Wagner
Carlo Serra, Kathryn R. Wagner
Published April 6, 2020
Citation Information: J Clin Invest. 2020;130(5):2186-2188. https://doi.org/10.1172/JCI136133.
View: Text | PDF
Commentary

It’s not all about muscle: fibroadipogenic progenitors contribute to facioscapulohumeral muscular dystrophy

  • Text
  • PDF
Abstract

Facioscapulohumeral muscular dystrophy (FSHD) results from expression of the full-length double homeobox 4 (DUX4-FL) retrogene in skeletal muscle. However, even in cases of severe FSHD the presence of DUX4 is barely detectable. In this issue of the JCI, Bosnakovski et al. used an inducible, muscle-specific human DUX4 to reproduce the low-level, sporadic DUX4 expression of human FSHD muscle as well the myopathology seen in human FSHD disease. Notably, dysregulated fibroadipogenic progenitors accumulated in affected muscles, thus providing a mechanism for the replacement of muscle by fibrosis and fat.

Authors

Carlo Serra, Kathryn R. Wagner

×

Figure 1

FAPs’ potential contribution to FSHD myopathy.

Options: View larger image (or click on image) Download as PowerPoint
FAPs’ potential contribution to FSHD myopathy.
Upon acute muscle injury,...
Upon acute muscle injury, normal muscle (center) shows necrosis of the damaged fibers and then the formation of new fibers by the fusion of the resident MuSCs (left). In this context, FAPs proliferate to assist this process and subsequently return to the basal level. Conversely, the continuous cycles of muscle necrosis and regeneration, as in FSHD, result in the excessive deposition of FAPs, a change that helps to explain the massive accumulation of fibrosis and intramuscular fat in the dystrophic muscle (right).

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts